IRMD vs OWLT
IRMD: A specialist medical device company providing the only known MRI-compatible non-magnetic IV infusion pumps and advanced patient vital signs monitoring systems for the magnetic resonance imaging environment. OWLT: Owlet provides FDA-cleared, wearable pediatric health monitors that bring clinical-grade data into the home to support infant wellness and parental peace of mind.
Side-by-side fundamentals
| Metric | IRMD | OWLT | Edge |
|---|---|---|---|
| Price as of 2026-07-22 close | $94.08 | $5.30 | |
| Market cap as of 2026-07-23 | $1.2B | $154M | |
| P/E as of 2026-07-23 | 51.42 | n/a | |
| PEG as of 2026-07-23 | 2.77 | -0.02 | OWLT lower |
| Net margin as of 2026-07-23 | +27.4% | -43.0% | IRMD higher |
| Gross margin as of 2026-07-23 | +76.8% | +50.9% | IRMD higher |
| Operating margin as of 2026-07-23 | +32.4% | -10.3% | IRMD higher |
| ROE as of 2026-07-23 | +24.5% | -35.1% | IRMD higher |
| ROA as of 2026-07-23 | +21.3% | -59.3% | IRMD higher |
| Debt / equity as of 2026-07-23 | 0.00 | 0.52 | IRMD lower |
| Revenue growth (YoY) as of 2026-07-23 | +14.8% | +26.8% | OWLT higher |
| Revenue CAGR (3y) SEC XBRL | +16.3% | +15.2% | IRMD higher |
| Dividend yield as of 2026-07-23 | +0.8% | n/a | |
| Dividend streak (yrs) SEC XBRL | 1 | n/a | |
| Beta as of 2026-07-23 | 0.92 | 1.89 | |
| 1-year return as of 2026-07-22 close | +69.0% | -28.7% | IRMD higher |
Fundamentals: Finnhub, as of 2026-07-23. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-22.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.